2096
COM:SIMCERE
Simcere Pharmaceutical Group
- Stock
Last Close
6.78
22/11 08:08
Market Cap
14.37B
Beta: -
Volume Today
3.31M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
asset turnover | 0.74 - | 0.71 4.34% | 0.74 4.51% | 0.41 44.65% | 0.49 19.43% | 0.59 19.12% | 0.61 3.87% | |
cash conversion cycle | -17.34 - | -34.88 101.09% | -2.74 92.14% | 8.35 404.54% | -30.01 459.25% | -8.85 70.50% | 212.93 2,505.13% | |
cash per share | 0.42 - | 0.56 34.14% | 0.35 37.85% | 1.26 262.63% | 0.84 33.31% | 1.00 19.97% | 0.76 24.07% | |
company equity multiplier | 2.92 - | 4.05 38.69% | 4.57 12.87% | 2.06 54.84% | 1.58 23.52% | 1.51 4.17% | 1.50 0.66% | |
days of inventory outstanding | 116.57 - | 110.69 5.04% | 101.95 7.89% | 106.54 4.50% | 79.48 25.40% | 83.47 5.02% | 138.15 65.52% | |
days of payables outstanding | 133.91 - | 145.56 8.70% | 104.70 28.08% | 98.18 6.22% | 109.49 11.51% | 92.32 15.68% | 71.31 22.76% | |
days of sales outstanding | 146.08 - | |||||||
dividend yield | 0.02 - | 0.04 62.17% | 0.02 - | 0.01 28.64% | ||||
ebit per revenue | 0.14 - | 0.21 52.11% | 0.23 11.45% | 0.13 46.05% | 0.14 9.67% | 0.14 0.80% | 0.11 18.79% | |
ebt per ebit | 0.94 - | 0.99 5.23% | 0.92 6.36% | 1.42 54.10% | 2.04 43.18% | 1.03 49.47% | 1.01 1.88% | |
effective tax rate | 0.30 - | 0.21 28.80% | 0.07 65.63% | 0.17 141.97% | -0.07 139.62% | -0.05 34.22% | 0.04 177.35% | |
enterprise value multiple | 29.62 - | 25.64 13.45% | 20.93 18.35% | 25.08 19.80% | 21.25 15.24% | 24.71 16.26% | 16.03 35.14% | |
fixed asset turnover | 3.26 - | 3.23 0.87% | 2.60 19.42% | 2.06 20.98% | 2.55 23.88% | 2.91 14.15% | 3.04 4.64% | |
free cash flow per share | 0.25 - | 0.17 31.89% | 0.10 39.82% | -0.10 196.48% | -0.16 60.66% | 0.26 264.31% | ||
gross profit margin | 0.85 - | 0.83 2.27% | 0.82 0.67% | 0.80 2.82% | 0.78 2.05% | 0.79 0.86% | 0.75 4.61% | |
interest coverage | 9.08 - | 19.82 118.27% | 10.10 49.02% | 4.23 58.13% | 9.71 129.54% | 25.07 158.17% | ||
inventory turnover | 3.13 - | 3.30 5.31% | 3.58 8.57% | 3.43 4.30% | 4.59 34.05% | 4.37 4.78% | 2.64 39.58% | |
long term debt to capitalization | 0.15 - | 0.07 50.71% | 0.46 543.60% | 0.22 53.03% | 0.01 94.74% | 0.02 87.78% | 0.04 106.59% | |
net income per ebt | 0.70 - | 0.79 12.07% | 0.93 17.47% | 0.83 10.36% | 1.08 29.28% | 1.05 2.31% | 0.97 8.04% | |
net profit margin | 0.09 - | 0.16 79.40% | 0.20 22.60% | 0.15 25.48% | 0.30 102.99% | 0.15 51.03% | 0.11 26.72% | |
operating cash flow per share | 0.36 - | 0.30 17.39% | 0.30 0.39% | 0.04 87.50% | -0.08 308.80% | 0.52 770.10% | ||
operating cycle | 116.57 - | 110.69 5.04% | 101.95 7.89% | 106.54 4.50% | 79.48 25.40% | 83.47 5.02% | 284.24 240.53% | |
operating profit margin | 0.14 - | 0.21 52.11% | 0.23 11.45% | 0.13 46.05% | 0.14 9.67% | 0.14 0.80% | 0.11 18.79% | |
payables turnover | 2.73 - | 2.51 8.01% | 3.49 39.04% | 3.72 6.63% | 3.33 10.32% | 3.95 18.59% | 5.12 29.46% | |
pretax profit margin | 0.13 - | 0.21 60.08% | 0.21 4.37% | 0.18 16.87% | 0.28 57.02% | 0.14 49.87% | 0.11 20.32% | |
price fair value | 13.32 - | 15.92 19.46% | 17.24 8.29% | 3.72 78.41% | 3.00 19.39% | 3.80 26.57% | 2.18 42.63% | |
receivables turnover | 2.50 - | |||||||
return on assets | 0.07 - | 0.12 71.61% | 0.15 28.13% | 0.06 58.75% | 0.15 142.43% | 0.09 41.67% | 0.07 23.88% | |
return on capital employed | 0.20 - | 0.42 112.31% | 0.35 17.05% | 0.08 78.35% | 0.10 27.59% | 0.11 13.83% | 0.09 18.72% | |
return on equity | 0.20 - | 0.47 138.01% | 0.68 44.62% | 0.13 81.37% | 0.23 85.40% | 0.13 44.10% | 0.10 24.39% | |
total debt to capitalization | 0.43 - | 0.60 40.29% | 0.67 11.43% | 0.38 42.32% | 0.20 47.18% | 0.17 13.88% | 0.16 9.80% |
All numbers in (except ratios and percentages)